July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Expression and Role of Nucleotide-binding Oligomerization Domain 2 (NOD2) in the Ocular Surface of Murine Dry Eye
Author Affiliations & Notes
  • Ying Li
    Department of ophthalmology, Chonnam National University Medical School & Hosp., Gwangju, Korea (the Democratic People's Republic of)
  • Ru Jun Jin
    Department of ophthalmology, Chonnam National University Medical School & Hosp., Gwangju, Korea (the Democratic People's Republic of)
  • Lan Li
    Department of ophthalmology, Chonnam National University Medical School & Hosp., Gwangju, Korea (the Democratic People's Republic of)
  • HYEON JEONG YOON
    Department of ophthalmology, Chonnam National University Medical School & Hosp., Gwangju, Korea (the Democratic People's Republic of)
  • In-Cheon You
    Department of Ophthalmology, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Korea (the Republic of)
  • Kyung Chul Yoon
    Department of ophthalmology, Chonnam National University Medical School & Hosp., Gwangju, Korea (the Democratic People's Republic of)
  • Footnotes
    Commercial Relationships   Ying Li, None; Ru Jun Jin, None; Lan Li, None; HYEON JEONG YOON, None; In-Cheon You, None; Kyung Chul Yoon, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 268. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ying Li, Ru Jun Jin, Lan Li, HYEON JEONG YOON, In-Cheon You, Kyung Chul Yoon; Expression and Role of Nucleotide-binding Oligomerization Domain 2 (NOD2) in the Ocular Surface of Murine Dry Eye. Invest. Ophthalmol. Vis. Sci. 2019;60(9):268. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate expression and role of nucleotide-binding oligomerization domain 2 (NOD2) in the ocular surface of dry eye, which is a NOD-like receptor member and is involved in innate immune response.

Methods : C57/BL6 female mice were divided into untreated (UT), experimental dry eye (EDE) and NOD2 knockout (KO) groups, and EDE and NOD2 KO groups created by desiccating stress for 14 days. Tear volume, tear film break-up time (TBUT), and corneal staining scores were measured at 7 and 14 days after induction. Expression of NOD2 in the ocular surface was evaluated using immunofluorescence at 14 days. Western blot for RIP2 and NF-kB were performed in the cornea and conjunctiva at 14 days. Concentrations of IL-1β, IL-6, IFN-γ, and TNF-α were measured in the cornea and conjunctiva using a multiplex immunobead assay at 14 days. Flow cytometric analysis for CD11b, DCF-DA, and CD4+CCR5+ T cells was also performed. Goblet cell density and apoptosis positive cells were observed using PAS staining and TUNEL staining.

Results : After desiccating stress, NOD2 was expressed in the cornea and conjunctiva of the EDE group. The NOD2 KO group showed a significant improvement in tear volume, TBUT, and corneal staining scores compared to the EDE group. Decreased expression of RIP2 and NF-kB was noted in the NOD2 KO group. Concentrations of IL-1β, IL-6, IFN-γ, and TNF-α and numbers of CD11b+ and CD4+CCR5+ T cells were lower in the NOD2 KO group than in the EDE group. Decreased DCF-DA and apoptosis positive cells and increased goblet cell density were observed in the NOD2 KO group compared to the EDE group (all p<0.05). In all results, EDE and NOD2 KO groups showed significant differences compared to the group.

Conclusions : The NOD2 receptor pathway induced inflammation and apoptosis by activation of RIP2 and NF-kB on the ocular surface after dry eye induction, thereby reducing tear secretion. Therefore, the NOD pathway may be involved in the pathogenesis of dry eye.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×